Dr. Javier Pérez Fernandez

Especialidad: Critical Care Medicine, Pulmonology
País: Estados Unidos

MD, FCCM, FCCP

Present

Chief Operating Officer and Medical Director, South Florida Critical Care Services, LLC
Intensive Care Solutions
8600 SW 92nd St, Suite 204b, Miami, FL 33156
President-Elect. World Federation Intensive and Critical Care (WFICC)
Medical Director Critical Care Services, Baptist Hospital of Miami, Miami, USA
Council Member, Federación Panamericana e Ibérica de Sociedades de Medicina Crítica y Terapia Intensiva (FEPIMCTI)
Director Critical Care Fellowship Training Program. Larkin Palm Springs Hospital
Associate Director Sleep Medicine Fellowship Training Program. Larkin Palm Springs Hospital
Associate Clinical Professor of Medicine, Florida International University, Herbert Wertheim College of Medicine

BOARD CERTIFICATION AND LICENSURES

ECFMG Permanent Certificate USMLE I, II and III
American Board of Internal Medicine
Pulmonary Disease
Critical Care

HIGHER EDUCATION

Universidad de Navarra, School of Medicine, 1987-1993

POST DOCTORAL TRAINING

Critical Care Medicine, 1999-2001
Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Illinois
Pulmonary Disease Training Program, 1997-1999
San Juan VA Medical Center, San Juan, Puerto Rico
Residency, Internal Medicine, 1994-1997
University of Puerto Rico, School of Medicine

APPOINTMENTS

8/2023 to present, President-Elect, and Council member World Federation Intensive and Critical Care (WFICC)
9/2021 to 8/2023, Secretary General, World Federation Intensive Care and Critical Care (WFICC)
2/2020 to present, Council Member and Past Treasurer, Panamerican and Iberian Federation of Critical Care and Intensive Care Societies (FEPIMCTI)
2/2018 to present. Chair Latin-American Council, Society of Critical Care Medicine
3/2020 to present. Editorial Board Journal of Clinical Immunology and Immunotherapy.
2/2020 to present. Chair, System-Wide Pulmonary Committee, Baptist Health South Florida
7/2007 to present, Medical Director, Critical Care Services Baptist Hospital of Miami
5/2010 to present. Credentials Committee West Kendall Baptist Hospital
7/2008 to present, Pharmacy and Therapeutic Committee, Baptist Health South Florida
5/2010 to present. Medical Director, Cardio-Pulmonary Services West Kendall Baptist Hospital

MEDICAL SOCIETIES

Fellow of the Society of Critical Care Medicine, 2018. Member since 1999
Fellow of the American College of Chest Physicians, 2002. Member since 1997.
Neurocritical Care Society. Member since 2020
Florida Medical Association. Member since 2002.
American Thoracic Society. Member since 1998
American Medical Association. Member since 1995
American College of Physicians. Member since1994

CLINICAL and ADMINISTRATIVE RESPONSIBILITIES

Chief Executive Officer South Florida Critical Care Services. Managing Intensive Care units at Baptist Hospital of Miami, West Kendall Hospital, South Miami Hospital, Palmetto General Hospital, Florida Medical Center, North Shore Hospital, Doctor’s Hospital, Coral Gables Hospital and Palm Springs Hospital
Chief Operating Officer (CEO) South Florida Pulmonary and Critical Care. Currently overseeing the performance of 46 physicians and 106 employees. Offering direct care to over 70,000 patients in South Florida as a member of the largest pulmonary practice.
Director Critical Care Services,Baptist Hospital of Miami. Direct care for 204 ICU and Step Down Beds
Director Critical Care Fellowship Training Program. Larkin Palm Springs Hospital
Associate Director Pulmonary and Critical Care Fellowship Training Program. Larkin Palm Springs Hospital
Associate Director Sleep Medicine Fellowship Training Program. Larkin Palm Springs Hospital
International Consultant for FCCS and FDM, Society of Critical Care Medicine

BOARDS AND COMMITTEES

2022 – Present. Board Member, Codigo Sepsis Foundation.
2010 – Present. Member, Credentials Committee West Kendall Baptist Hospital
2007 – Present. Member Physician Steering Committee.
2007 – Present. Chairman. Critical Care Collaborative Committee Baptist Hospital of Miami
2009 – Present. Member of the P & T Committee, Baptist Health South Florida

RESEARCH EXPERIENCE

RSF100-001 Avaptadil for patients with COVID19 related Respiratory Failure
RESTEM. Umbilical Cord Lining Stem Cells in patients with COVID19. Ongoing
CONVALESCENT PLASMA in patients with COVID19. Ongoing.
D5896C00021-Asthma. Principal Investigator. Astra-Zeneca Sponsored Trial. Finished
Protocol Q3662g-Asthma. Principal Investigator. Genentech Sponsored Trial. Finished
ADA109057-Asthma. Principal Investigator. Glaxo-Smith-Kline Sponsored Trial. Finished
SFA100062. Double blind placebo control trial for mild to moderate asthma. Glaxo-Smith Kline Sponsored Trial. Pulmonary Group of South Florida 2004-2006.
NACR Trial. Effectiveness of Airway Clearance Devices on QOL of COPD. 2004-2006. Pulmonary Group of South Florida.
Clinical efficacy of protocols in the ICU. Multicenter Prospective study. Rush-Presbyterian-St. Luke’s Medical Center: PI: R. Phillip Dellinger, Chicago, IL.
In-hospital cardiac arrests: A ten-year experience at a county hospital. Retrospective, record review analysis. Abstract presented at the 2001 Society of Critical Care Medicine.
The effect of Nitric Oxide on the Pulmonary Circulation in ARDS patients receiving vasoactive substances. Rush-Presbyterian-St. Luke’s Medical Center: PI: R. Phillip Dellinger, M.D.
F1K-MC-EVAD (PROWESS): A phase III study to determine the efficacy and safety for Recombinant Human Activated Protein C in severe sepsis. Eli-Lilly Co. Rush-Presbyterian-St. Luke’s Medical Center. October 1999-June 2000. Co-investigator.
A comparison between contrast echocardiography and thermodilution to determine cardiac output in critically ill patients. Rush-Presbyterian-St. Luke’s Medical Center. Co-investigator.
Prospective, randomized, double-blind, multicenter comparison of the safety and efficacy of sequential (IV to p.o.) BAY 12-8039 400/400 mg q.d for 7-14 days versus sequential Trovan™ IV/Trovan™ tablets 200/200 mg q.d. for 7-14 days in the treatment of patients with community acquired pneumonia. Bayer Pharmaceuticals Co. San Juan VA Medical Center. December 1998-June 1999. Co-investigator.
J4A-MC-EZZF: A phase II Study to determine the efficacy and safety of LY 315920 in patients with severe sepsis. Eli-Lilly Co. San Juan VA Medical Center. December 1998-June 1999. Co-investigator.
Tuberculin Skin Testing. Prevalence of tuberculosis infection among health sciences students in Puerto Rico. Descriptive, cohort study. January 1999-2001. Co-investigator.
The effect of CPAP therapy in hypertension in sleep apnea patients. San Juan VA Medical Center. April 1999-July 2001. Co-investigator.
Pulmonary and infectious disease specialists in Puerto Rico: attitudes toward tuberculosis. San Juan VA Medical Center. January 1998-March 1998.